Antinociceptive activity of impentamine, a histamine congener, after CNS administration

Life Sciences

Volumn 64, Issue 5, 1998, Pages

  Hough, Lindsay B ^a   Nalwalk, J W ^a   Leurs, R ^b   Menge, W M P B ^b   Timmerman, H ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Analgesia; Antinociception; H1 receptor; H2 receptor; H3 receptor; Histamine; Improgan

Indexed keywords

1 CYANO 2 [2 [(4 IMIDAZOLYL)METHYL]ETHYL] 3 METHYLGUANIDINE; DRUG VEHICLE; HISTAMINE DERIVATIVE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; IMPENTAMINE; IMPROGAN; MEPYRAMINE MALEATE; SODIUM CHLORIDE; THIOPERAMIDE; UNCLASSIFIED DRUG; ZOLANTIDINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GUINEA PIG; HOT PLATE TEST; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICROINJECTION; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

ANIMALIA; CAVIA PORCELLUS; RODENTIA; SUS SCROFA;

EID: 0033601473     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00571-2     Document Type: Article

References (22)

1. 1. K.R. Gogas and L.B. Hough, J. Pharmacol. Exp. Ther. 248 262-267 (1989).
2. 2. K.E. Barke and L.B. Hough, J. Neurochem. 63 238-244 (1994).
3. 3. S.D. Glick and L.A. Crane, Nature 273 547-549 (1978).
4. 4. K. Onodera and Y. Ogura, Jap. J. Oral Biol. 25 1144-1147 (1983).
5. 5. S.K. Bhattacharya and S.S. Parmar, Res. Comm. Chem. Path. Pharmacol. 49 125-136 (1985).
6. 6. D. Parolaro, G. Patrini, P. Massi, P. Mainardi, G. Giagnoni, M. Sala and E. Gori, J. Pharmacol. Exp. Ther. 249 324-328 (1989).
7. 7. C. Lamberti, A. Bartolini, C. Ghelardini and P. Malmberg-Aiello, Pharmacol. Biochem. Behav. 53 567-574 (1996).
8. 8. C. Netti, F. Guidobono, V. Sibilia, I. Villa, E. Cazzamalli and A. Pecile, Agents Actions 23 247-249 (1988).
9. 9. K.K. Thoburn, L.B. Hough, J.W. Nalwalk and S.A. Mischler, Pain 58 29-37 (1994).
10. 10. B.Y. Li, J.W. Nalwalk and L.B. Hough, Brain Res. 748 168-174 (1997).
11. 11. B.Y. Li, J.W. Nalwalk, L.A. Barker, P. Cumming, M.E. Parsons and L.B. Hough, J. Pharmacol. Exp. Ther. 276 500-508 (1996).
12. 12. B.Y. Li, J.W. Nalwalk, J.M. Finkel, S.D. Glick and L.B. Hough, Analgesia 3 15-20 (1997).
13. 13. C. Netti, R. Bossa, I. Galatulas, V. Sibilia and A. Pecile, Pharmacology 28 262-267 (1984).
14. 14. A.O. Oluyomi and S.L. Hart, Neuropharmacology 30 1021-1027 (1991).
15. 15. J.C. Leza, I. Lizasoain and P. Lorenzo, Methods Find. Exp. Clin. Pharm. 12 671-678 (1990).
16. 16. L.B. Hough, J.W. Nalwalk, B.Y. Li, R. Leurs, W.M.P.B. Menge, H. Timmerman, C. Cioffi and M. Wentland, J. Pharmacol. Exp. Ther. 283 1534-1543 (1997).
17. 17. R.C. Vollinga, W.M.P.B. Menge, R. Leurs and H. Timmerman, J. Med. Chem. 38 266-271 (1995).
18. 18. R. Leurs, M. Kathmann, R.C. Vollinga, W.M.P.B. Menge, E. Schlicker and H. Timmerman, J. Pharmacol. Exp. Ther. 276 1009-1015 (1996).
19. 19. L.A. Crane and S.D. Glick, Pharmacol. Biochem. Behav. 10 799-800 (1979).
20. nd ed., Academic Press, Sydney (1988).
21. 21. F.E. D'Amour and D.L. Smith, J. Pharmacol. Exp. Ther. 72 74-79 (1941).
22. 22. N.B. Eddy and D. Leimbach, J. Pharmacol. Exp. Ther. 107 385-393 (1953).